Pharmacotherapeutics for Nurse Practitioner Prescribers, Second Edition

Cover Page......Page 1
Title Page......Page 2
Copyright Page......Page 3
Dedication......Page 4
Preface......Page 6
Acknowledgments......Page 10
About the Authors......Page 12
Contributors......Page 14
Reviewers......Page 16
Contents......Page 18
UNIT I: The Foundation......Page 22
CHAPTER 1: THE ROLE OF THE NURSE PRACTITIONER AS PRESCRIBER......Page 24
CHAPTER 2: REVIEW OF BASIC PRINCIPLES OF PHARMACOLOGY......Page 34
CHAPTER 3: ADVERSE DRUG REACTIONS......Page 44
CHAPTER 4: PHARMACOGENOMICS......Page 50
CHAPTER 5: PHARMACOECONOMICS......Page 58
CHAPTER 6: RATIONAL DRUG SELECTION......Page 64
CHAPTER 7: LEGAL AND PROFESSIONAL ISSUES IN PRESCRIBING......Page 74
CHAPTER 8: FOSTERING ADHERENCE AND POSITIVE OUTCOMES......Page 84
CHAPTER 9: CULTURAL AND ETHNIC INFLUENCES IN PHARMACOTHERAPEUTICS......Page 94
CHAPTER 10: NUTRITION AND DRUG THERAPY......Page 104
CHAPTER 11: HERBAL THERAPY......Page 110
CHAPTER 12: INFORMATION TECHNOLOGY AND PHARMACOLOGY......Page 122
CHAPTER 13: OVER-THE-COUNTER MEDICATIONS......Page 144
UNIT II: Pharmacotherapeutics With Single Drugs......Page 158
CHAPTER 14: DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM......Page 160
CHAPTER 15: DRUGS AFFECTING THE CENTRAL NERVOUS SYSTEM......Page 210
CHAPTER 16: DRUGS AFFECTING THE CARDIOVASCULAR AND RENAL SYSTEMS......Page 264
CHAPTER 17: DRUGS AFFECTING THE RESPIRATORY SYSTEM......Page 332
CHAPTER 18: DRUGS AFFECTING THE HEMATOPOIETIC SYSTEM......Page 388
CHAPTER 19: DRUGS AFFECTING THE IMMUNE SYSTEM......Page 420
CHAPTER 20: DRUGS AFFECTING THE GASTROINTESTINAL SYSTEM......Page 460
CHAPTER 21: DRUGS AFFECTING THE ENDOCRINE SYSTEM......Page 504
CHAPTER 22: DRUGS AFFECTING THE REPRODUCTIVE SYSTEM......Page 560
CHAPTER 23: DRUGS AFFECTING THE INTEGUMENTARY SYSTEM......Page 588
CHAPTER 24: DRUGS USED IN TREATING INFECTIOUS DISEASES......Page 646
CHAPTER 25: DRUGS USED IN TREATING INFLAMMATORY PROCESSES......Page 766
CHAPTER 26: DRUGS USED IN TREATING EYE AND EAR DISORDERS......Page 804
UNIT III: Pharmacotherapeutics With Multiple Drugs......Page 832
CHAPTER 27: ANEMIA......Page 834
CHAPTER 28: CHRONIC STABLE ANGINA AND LOW-RISK UNSTABLE ANGINA......Page 850
CHAPTER 29: ANXIETY AND DEPRESSION......Page 866
CHAPTER 30: ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE......Page 884
CHAPTER 31: CONTRACEPTION......Page 912
CHAPTER 32: DERMATOLOGIC CONDITIONS......Page 926
CHAPTER 33: DIABETES MELLITUS......Page 960
CHAPTER 34: GASTROESOPHAGEAL REFLUX AND PEPTIC ULCER DISEASE......Page 986
CHAPTER 35: HEADACHES......Page 1004
CHAPTER 36: HEART FAILURE......Page 1030
CHAPTER 37: HUMAN IMMUNODEFICIENCY VIRUS DISEASE AND ACQUIRED IMMUNODEFICIENCY DISEASE......Page 1050
CHAPTER 38: HORMONE REPLACEMENT THERAPY AND OSTEOPOROSIS......Page 1066
CHAPTER 39: HYPERLIPIDEMIA......Page 1090
CHAPTER 40: HYPERTENSION......Page 1114
CHAPTER 41: HYPERTHYROIDISM AND HYPOTHYROIDISM......Page 1136
CHAPTER 42: PAIN MANAGEMENT: ACUTE AND CHRONIC PAIN......Page 1154
CHAPTER 43: PNEUMONIA......Page 1178
CHAPTER 44: SMOKING CESSATION......Page 1188
CHAPTER 45: SEXUALLY TRANSMITTED DISEASES AND VAGINITIS......Page 1200
CHAPTER 46: TUBERCULOSIS......Page 1216
CHAPTER 47: UPPER RESPIRATORY INFECTIONS: VIRAL UPPER RESPIRATORY INFECTION, SINUSITIS, OTITIS MEDIA, AND OTITIS EXTERNA......Page 1232
CHAPTER 48: URINARY TRACT INFECTIONS......Page 1246
UNIT IV: Special Drug Treatment Considerations......Page 1258
CHAPTER 49: WOMEN AS PATIENTS......Page 1260
CHAPTER 50: PEDIATRIC PATIENTS......Page 1276
CHAPTER 51: GERIATRIC PATIENTS......Page 1290
CHAPTER 52: CHRONIC ILLNESS AND LONG-TERM CARE......Page 1304
CHAPTER 53: DRUG THERAPY AT THE END OF LIFE......Page 1316
Index......Page 1328